The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| BICO | -41.54% | -91.63% | -39.09% | +39% |
| S&P | +14.77% | +87.2% | +13.35% | +232% |
BICO Group AB
The company is poised to play a leading role in the life science industry.
The company faced some challenges in 2021.
| Q3 2025 | YOY Change | |
|---|---|---|
| Revenue | $386.90M | -21.9% |
| Gross Profit | $165.70M | -9.4% |
| Gross Margin | 42.83% | 5.9% |
| Market Cap | $1.40B | -55.5% |
| Market Cap / Employee | $2.32M | 0.0% |
| Employees | 602 | 0.0% |
| Net Income | -$1,107,500.00K | -347.5% |
| EBITDA | $22.40M | -26.6% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q3 2025 | YOY Change | |
|---|---|---|
| Net Cash | $1.24B | 90.9% |
| Accounts Receivable | $363.70M | -13.8% |
| Inventory | 231 | -18.5% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $233.20M | -87.0% |
| Short Term Debt | $1.06B | 898.0% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Return On Assets | -27.39% | -10.2% |
| Return On Invested Capital | -4.57% | 2.1% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | -$36,500.00K | -205.8% |
| Operating Free Cash Flow | -$31,500.00K | -170.0% |
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Book | 0.82 | 0.72 | 0.96 | 0.57 | -46.29% |
| Price to Sales | 1.07 | 1.08 | 1.42 | 0.84 | -41.98% |
| Price to Tangible Book Value | -22.09 | -184.22 | 25.81 | -186.41 | 1183.85% |
| Price to Free Cash Flow TTM | 19.77 | 10.12 | 10.17 | 7.85 | -76.52% |
| Enterprise Value to EBITDA | 27.29 | -167.55 | -51.41 | 64.99 | -55.04% |
| Free Cash Flow Yield | 5.1% | 9.9% | 9.8% | 12.7% | 325.87% |
| Return on Equity | -2.4% | -10.6% | -14.9% | -55.3% | 94.75% |
| Total Debt | $1.76B | $1.41B | $1.41B | $1.30B | -31.56% |
No transcripts available.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
